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ABSTRACT
Summary: In anticipation of the individualized proteomics era and the
need to integrate knowledge from disease studies, we have augmen-
ted our peptide identification software RAId DbS to take into account
annotated single amino acid polymorphisms, post-translational modi-
fications, and their documented disease associations while analyzing
a tandem mass spectrum. To facilitate new discoveries, RAId DbS
allows users to conduct searches permitting novel polymorphisms.
Availability: The webserver link is http://www.ncbi.nlm.nih.gov/
/CBBResearch/qmbp/raid dbs/index.html. The relevant databases
and binaries of RAId DbS for Linux, Windows, and Mac OS X are
available from the same web page.
Contact: yyu@ncbi.nlm.nih.gov
Introduction
Like single nucleotide polymorphisms (SNPs) that occur roughly
every 300 base pairs (Collins et al., 1998), single amino acid
polymorphisms (SAPs) also differentiate individuals from one ano-
ther. In addition to from nonsynonymous SNPs, SAPs may result
from post-transcriptional regulations such as mRNA editing. SAPs
together with post-translational modifications (PTMs) often distin-
guish healthy/diseased forms of proteins. Integration of this annota-
ted, disease-related knowledge with data analysis facilitates speedy,
dynamic information retrieval that may significantly benefit clinical
laboratory studies.
To incorporate knowlege information within peptide searches, we
start by constructing a human protein database where information
about annotated SNPs, SAPs, PTMs, and their disease associations
(if any) are integrated. We have also modified our peptide identifi-
cation software RAId DbS (Alves et al., 2007a) to take into account
this additional information while performing peptide searches. Con-
sequently, part of our work may be considered an improvement
over that of Schandorff et al. (2007) who extended the human pro-
tein database to include only SAPs but without PTMs and without
integration of disease information.
Besides using our web server, a user may also download a stan-
dalone executable to be installed on her/his local machines. Once a
user chooses to do so, she/he will find an important feature of the
standalone version: the flexibility for users to add their own SAP
and/or PTM information to various proteins they are interested in
and even to add new protein sequences to the database.
Implementation Summary
In addition to giving a brief introduction to our software RAId DbS
and its augmentation, we focus in this section on explaining how
we accommodate the SAPs, PTMs, and their disease associations
∗to whom correspondence should be addressed: yyu@ncbi.nlm.nih.gov
in our database. Appropriate comparison to existing approaches
will also be discussed. Prior to database construction, we per-
form a information-preserved protein clustering (see supplementary
information).
Database Construction To minimize inclusion of less confident
annotations, we only keep the SAPs and PTMs that are consistently
documented in more than one source. For example, for proteins with
Swiss-Prot accession number, we only keep the SAPs and PTMs
that are annotated both by Swiss-Prot and GeneBank. For proteins
without Swiss-Prot accession numbers, the retentions of SAPs and
PTMs are described in the supplementary information.
A typical sequence in our augmented human protein database
carries with it annotated SAPs and PTMs in a simple format, see
Figure 1 and its caption. Our data format minimizes redundancy. For
example, if a single site contains two SAPs, construction method
proposed by Schandorff et al. (2007) will demand two almost iden-
tical partial sequences, each may be several tens of amino acids in
length, be appended after the primary sequence, while in our case it
only takes up a few additional bytes. The compactness of our data-
base becomes obvious when incorporating the information of two
nearby sites, each containing several annotated SAPs and PTMs,
into the database. In our construction, we only need a few additio-
nal bytes. But in other approaches, it may introduce a combinatorial
expansion due to including/excluding and pairing of different varia-
tions at both sites along with the flanking peptides. Another key
difference between our method and other database methods is that
we do not need to limit the number of enzymatic miscleavages.
When needed, users of RAId DbS may modify the database, add
new sequences, or even create their own databases following the
same format. There is a separate information file that contains the
protein accession numbers, detailed SAP and PTM information,
and disease associations. If one wishes to add additional SAPs or
PTMs, one simply updates both the ASCII database file as well as
the information file. When reporting a hit with annotated SAPs or
PTMs, RAId DbS automatically reports the corresponding detailed
information and disease association if it exists.
RAId DbS Augmentation Taking into account the finite sample
effect and skewness, the asymptotic score statistics (P -values) of
RAId DbS (Alves et al., 2007a) is derived theoretically. The final
E-value for each peptide hit, however, is obtained by multiplying
the peptide’s P -value by the number of peptides of its category.
RAId DbS then ranks peptide hits according to E-values, not P -
values. This avoids overstating the significance of a hit from a
larger effective database and is particularly helpful in reducing false
positives when we allow SAPs and PTMs in the searches (see the
supplementary information for details).
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Table 1. Example search results of augmented RAId DbS.
(a) E-value P -value Peptide Mol. Wt. Protein ID Novel SAP Disease
1.184e-01 1.744e-05 RTKLKDC. . . KIAR 2897.500 (NP 114412;. . . ;Q9H2L5) disabled
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
4.084e+00 9.345e-03 KQQELAA. . . VSSR 2898.520 (NP 072096;. . . ;O75420) disabled
(b) E-value P -value Peptide Mol. Wt. Protein ID Novel SAP Disease
3.977e-07 1.834e-10 KsVEEYANCHLAR 1448.650 (NP 001054;. . . ;P02787) disabled
4.779e-01 2.205e-04 KsVqEYANCHLAR 1447.670 (NP 001054;. . . ;P02787) disabled
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
7.524e-01 3.470e-04 RℓMNAsMVWAQAAR 1448.720 (NP 000337;. . . ;P48436) disabled {(ℓ;2;108;Campomelic dysplasia (CMD1) [MIM:114290])
(s;6;112;Campomelic dysplasia (CMD1) [MIM:114290]) }
RAId DbS by default perform searches considering the parent ion to have charge +1, +2, +3. The search results are then pooled together to form a single result ranked by
E-values. This is why for the same spectrum RAId DbS may report peptide hits with very different masses. In part (a) ((b)), searches were done with annotated SAPs and PTMs
turned off (on). The lowercase letters in the peptide indicate SAPs. A novel SAP, if present and enabled in the searches, will be specified in the column headed by Novel SAP.
Note that in the disease related annotation, there are four fields separated by three semicolons. The first field, a lower case amino acid letter, indicates the SAP; second field, an
integer, indexes the SAP position in the peptide; the third field, an integer, indexes the SAP position in the protein; the fourth field shows the annotated disease association.
In addition to performing database searches that consider annota-
ted SAPs and PTMs, we also allow users to include for consideration
one novel SAP per peptide. This feature, helpful for scrutinizing
otherwise unidentifiable spectra, will increase the effective peptide
database size. However, it does not cause harm since the E-values
associated with peptide hits containing novel SAPs are obtained by
multiplying their P -values with a much larger number than that for
peptide hits without novel SAPs (see supplementary information for
details).
Example
Using a tandem mass (MS2) spectrum taken from the profile data-
set described earlier (Alves et al., 2007b), we illustrate in Table 1
two search results in the human protein database with the annota-
ted SAPs and PTMs turned off (a) and on (b) respectively. In case
(a), the best hit is a false positive with E-value about 0.11 imply-
ing that one probably ends up declaring no significant peptide hit
for this spectrum. In case (b), however, the best hit is a true posi-
tive (a peptide from human transferin with an annotated SAP) with
E-value about 4.0 × 10−7. This example shows that if properly
used, allowing SAPs/PTMs may increase peptide identification rate.
That is, it may be fruitful to turn on the SAPs/PTMs when a regu-
lar search returns no significant hit. Blindly turn on SAPs/PTMs,
however, may cause loss of sensitivity due to the increase of search
space. In supplementary information, using the 54 training spectra
of PEAKS, we compare RAId DbS’s peptide identifications with
and without SAPs/PTMs. The purpose is to study the degree of loss
in senstivity when turning on the SAPs/PTMs. Although for the
data set tested there is no obvious loss in sensitivity (perhaps due
MLLATLLLLLLGGALAHPDRIIFPNHACEDPPAVLLEVQGTLQRPLVR〈{W00}〉D
SRTSPAN〈(N08,N09,N10,N11,N12)〉CTWLILGSKEQTVTIRFQKLHLACGSERL
TLRSPLQPLISLCEAPPSPLQLPGGN〈(N08,N09,N10,N11,N12)〉VTITYSYAGA
RAPMGQGFLLSYSQDWLM〈{V00}〉CLQEEFQCLNHRCVSAVQR............[
Fig. 1. Protein sequence (NP 054764) used as an example to demonstrate
our database structure. A “[” character is always inserted after the last amino
acid of each protein to serve as a separator. Annotated SAPs and PTMs asso-
ciated with an amino acid are included in a pair of angular brackets following
that amino acid. SAPs are further enclosed by a pair of curly brackets while
PTMs are further enclosed by a pair of round brackets. Amino acid follo-
wed by two zeros indicates an annotated SAP. Every annotated PTM has a
two-digit positive integer that is used to distinguish different modifications.
to the statistical accuracy of RAId DbS), we recommend running
searches with SAPs/PTMs on only when a regular search returns no
significant hit.
Conclusion
To enable speedy information retrieval and to enhance the protein
coverage while analyzing MS2 peptide spectra, we have augmented
the capability of RAId DbS and integrated with protein database
additional information such as SAPs, PTMs, and disease annotati-
ons. Incorporation of known SAPs and PTMs during initial searches
may enhance the peptide identification rate. Integration of disease
knowledge and information may be crucial in many time-pressed
clinical uses.
We are currently investigating the possibility of combining
various isoforms of proteins into a single entry in addition to cluste-
ring almost identical proteins. We are experimenting with keeping
the longest form of the protein and marking at the beginning of the
sequence possible deletions. Once achieved, this enhancement will
further reduce redundant searches which should result in a shorter
run time. Another objective is to cover more organisms. Currently,
we have finished database construction of 17 organisms, including
Homo sapiens, Drosophila melanogaster, Saccharomyces cerevisiae
etc. (see supplementary information for details). We will provide
more organismal databases on our web server once constructed.
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SUPPLEMENTARY INFORMATION
Information-preserved Protein Clustering and Database
Construction
We extract 34, 197 human protein sequences with a total of
16, 814, 674 amino acids from the file (last updated 09/05/2006)
ftp://ftp.ncbi.nlm.nih.gov/genomes/H sapiens/protein/protein.gbk.gz.
Each protein sequence is accompanied by a list of annotated SAPs
and PTMs. Out of the 34, 197 proteins, we found 29, 979 uni-
que proteins with a total of 15, 324, 913 amino acids. To avoid
having multiple copies of identical or almost identical proteins in
the database, we first cluster the 34, 197 sequences by running
an all-against-all BLAST. Two sequences with identical lengths
and aligned gaplessly with less than 2% mismatches are clustered
together, and each sequence is called a qualified hit of the other.
Any other sequence that satisfies this condition with a member of
an existing cluster is assigned to that existing cluster. All the anno-
tations in the same cluster are then merged. We find it possible for
every given cluster to choose a consensus sequence that will make
all other members its polymorphous forms. Hence, we only retain
one protein sequence for each of the 29, 272 clusters. The total num-
ber of amino acids associated with these 27, 272 consensus proteins
is 15, 001, 326.
Although we only retain one sequence (the consensus sequence)
per cluster, the information of other member sequences are still kept.
For example, when a member sequence and the consensus sequence
disagree at two sites, the presence of the member sequence is docu-
mented by introducing two cluster-induced SAPs at the two sites of
the consensus sequence. The originally annotated SAPs and PTMs
of the member sequence are also merged into those of the consensus
sequence. Figure 2 illustrates how this is process is done iteratively.
In our information file, each SAP or PTM is documented with its
origin. SAPs arising from clustering are easily distinguished from
annotated SAPs. For member sequences that are identical to the con-
sensus sequence, the accession number of those member sequences
are also recorded with their SAPs/PTMs annotations merged into
the consensus sequence. When a user selects not to have annotated
SAPs, RAId DbS still allows for cluster-induced SAPs resulting in
an effective search of the original databases but with minimum red-
undancy. The strategy employed by RAId DbS to search for SAPs
and PTMs will be briefly described in the RAId DbS section below.
The consensus protein in a given cluster is then used as a
query to BLAST against the NCBI’s nr database to retrieve
its RefSeq accession number and its corresponding Swiss-Prot
(http://ca.expasy.org/sprot/) accession number, if it exists, from the
best qualified hit. It is possible for a cluster to have more than one
accession number. This happens when there is a tie in the qualified
best hits and when a protein sequence in nr actually is documented
with more than one accession number.
To minimize inclusion of less confident annotations, we only
keep the SAPs and PTMs that are consistently documented in
more than one source. For example, for proteins with Swiss-
Prot accession number, we only keep the SAPs and PTMs
that are annotated both by Swiss-Prot and GeneBank. For pro-
teins without Swiss-Prot accession numbers, the retentions of
SAPs and PTMs are described below. The PTM annotations
are kept only if they are present in the gzipped document
consensus seq. . . . DPR. . . . . . . . . LQRLVADN〈(N08)〉GSE . . .
member seq. . . . DPR〈{W00}〉. . . LKRLVVDN〈(N11)〉GSE . . .
updated consensus seq.
. . . DPR〈{W00}〉. . . LQ〈{K00}〉RLVA〈{V00}〉DN〈(N08,N11)〉GSE. . .
Fig. 2. Information-preserved protein clustering example. Once a consen-
sus sequence is selected, members of the clusters are merged into the
consensus one-by-one. This figure illustrates how the information of a mem-
ber sequence is merged into the consensus sequence. The difference in
the primary sequences between a member and the consensus introduces
cluster-induced SAPs. In this example, the residues Q and A (in red) in
the consensus are different from the residues K and V (in blue) in the
member sequence. As a consequence, K becomes a cluster-induced SAP
associated with Q and V becomes a cluster-induced SAP associated with
A at these respective sites of the consensus. The annotated SAP, {W00},
associated with residue R in the member sequence is merged into the con-
sensus sequence, see the updated consensus sequence in the figure. Note
that the annotated PTM, 〈(N11)〉, associated with N in the member sequence
is merged with a different annotated PTM, 〈(N08)〉, at the same site of
the consensus sequence. As mentioned earlier, although the SAPs, PTMs
are merged, each annotation’s origin and disease associations are kept in
the information file allowing for faithful information retrieval at the final
reporting stage of the RAId DbS program.
HPRD FLAT FILES 090107.tar.gz of the Human Protein Refe-
rence Database: http://www.hprd.org/download. The SAP annota-
tions are kept only if they are in agreement with the master table,
SNP mRNA pos.bcp.gz (last updated 01/10/2007), of dbSNP:
ftp://ftp.ncbi.nlm.nih.gov/snp/organisms/human 9606//database/organism data.
RAId DbS
Taking into account the finite sample effect and skewness, the form
of asymptotic score statistics (P -values) of RAId DbS (Alves et al.,
2007a) is derived theoretically. Since the skewness varies per spec-
trum, the parameters for our theoretical distribution are spectrum-
specific. For each spectrum considered, our theoretical distribution
(used to compute P -value) mostly agrees well with the score histo-
gram accumulated. The final E-value for each peptide hit, however,
is obtained by multiplying the peptide’s P -value by the number
of peptides of its category. As a specific example, when Trypsin
is used as the digesting enzyme, RAId DbS allows for incorrect
N-terminal cleavages. RAId DbS has internal counters, Cc and
Cinc, counting respectively the number of scored peptides with
correct and incorrect N-terminal cleavage. In general, Cinc ≫
Cc. When calculating the E-value of a peptide with correct N-
terminal cleavage, RAId DbS multiplies the peptide’s P -value by
Cc. However, the E-value of a peptide with incorrect N-terminal
cleavage will be obtained by multiplying the peptide’s P -value by
Cc +Cinc (Alves et al., 2007a). In line with the Bonferroni correc-
tion, our approach avoids overstating the significance of a hit from a
larger effective database (the pool of peptides regardless of whether
the N-terminal cleavage is correct) versus a hit from a smaller effec-
tive database (the pool of peptides with correct N-terminal cleavage
only).
The same idea is used in the augmented RAId DbS. That is, dif-
ferent counters are set up to record the number of scored peptides
in different categories. As a specific example, when novel SAPs are
allowed, RAId DbS creates a new counter, Cnovel sap, to record the
number of scored peptides with a novel SAP. This is in general a
3
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much larger number than other counters. When one calculates the
E-value associated with a peptide hit that contains a novel SAP, one
will multiply the peptide’s P -value by the sum of a number of cout-
ners with Cnovel sap included. However, in the same search, for a
peptide without novel SAP, its E-value is obtained by multiplying
the peptide’s P -value by the sum of a number of counters exclu-
ding Cnovel sap. The same approach is applied to PTMs and other
annotations.
Below we briefly sketch how RAId DbS deals with the presence
of annotated SAPs, PTMs as well as novel SAPs. In our data-
base format, annotated SAPs and PTMs are inserted right after the
site of variation. When searching the database for peptides with
parent ion mass 1500 Da, RAId DbS sums the masses of amino
acids within each possible peptide to see if the total mass is within
3 Da of 1500 Da. At this stage, sites with variations will have,
instead of a fixed mass, several possible masses depending on the
number of SAPs/PTMs are annotated at these sites. Each peptide
fragmnent covering some of those sites will therefore have several
effective masses, each corresponding to a specific arrangement of
SAPs/PTMs. If some of these masses happens to be within 3 Da
of 1500 Da, RAId DbS will score this peptide with corresponding
annotated SAPs/PTMs that give rise to the proper masses. If none
of these masses are within the allowed molecular mass range, that
peptide will not be scored. Note that this approach is computatio-
nally efficient in terms of mass selection. For example, if a peptide
contains a site with annotated SAPs/PTMs, one computes the mass
of this peptide by summing once the amino acid masses of other
sites. It is then a simple matter to see whether the addition of this
sum to the list of masses associated with the site with SAPs/PTMs
may fall in the desriable mass range. This approach is particularly
powerful when there are more than one site with SAPs/PTMs in
the peptide considered. The combinatorics associated with two sites
with SAPs/PTMs only result in a longer list of possible masses to be
added to the mass sum of unvaried sites. This should be constrasted
with methods that incorporate SAPs via appending polymorphous
peptides to the end of the primary sequence. In the latter approach,
the program needs to do the mass sum multiple times, repeating the
mass sum of unvaried sites, and thus may significantly slow down
the searches.
Despite RAId DbS’s strategic advantage, introduction of
SAPs/PTMs does increase the complexity of the algorithm. The-
refore, we limit per peptide the maximum number of annotated
SAPs to be 2 and the maximum number of annotated PTMs to
be 5. To facilitate discovery, RAId DbS also permits novel SAPs,
but limited to one novel SAP per not-yet-annotated peptide, mea-
ning peptides that do not contain any annotated SAPs/PTMs. This
is because the introduction of novel SAP largely expand the search
space, and if one allows novel SAPs on peptides already documen-
ted with SAPs/PTMs, the search space expansion will be even larger
and may render the search intractable. Currently, the novel SAP is
expedited via a pre-computed list of amino acid mass difference. As
an example, assume that one is searching for a peptide with parent
ion mass 1500 Da, and a not-yet-annotated candidate peptide has
mass 1477 Da, 23 Da smaller than the target mass. It happens that
23 Da is also the mass difference between Tryptophan and Tyro-
sine, and if the candidate peptide contains a Tyrosine, RAId DbS
will replace that Tyrosine with a Tryptophan and score the new pep-
tide. If the candidate peptide contains two Tyrosines, RAId DbS
will replace one Tyrosine at a time with a Tryptophan and score
both the new peptides. It is evident that the complexity grows fast if
one were to allow for two novel SAPs per petpide.
It is commonly believed that when searching in a larger data-
base, one is bound to loose sensitivity. This may be true if the
E-value for every hit is obtained by multiplying the peptide’s P -
value by the same number regardless of the category that peptide
belongs to. As we have explained earlier, RAId DbS does not do
that. It uses a method equivalent to Bonferroni correction. We use
E-values to rank peptide hits and each peptide’s E-value is obtai-
ned by multiplying its P -value by the corresponding size of the
effective database that the peptide belongs to. Consequently, pep-
tide hits falling in a category that has a large effective database
size essentially need to have smaller P -values than those of pep-
tide hits falling in a category that has a small effective database
size. In Figure 3, we show the Receiver Operating Characteristic
(ROC) curves when analyzing the training 54 spectra of PEAKS.
In this data set, there are 17 spectra from yeast, 23 spectra from
bovine, and 14 spectra from horse. The true positive proteins are
already provided by PEAKS. We search the spectra generated by
proteins of yeast, bovine, and horse respectively in the databases
fo yeast, bovine, and horse. Since the true positive proteins are
already known, it is relatively easy to perform the ROC analysis
using the search results from the 54 spectra. There are three ROC
curves shown in Figure 3, one for searches without SAPs/PTMs, one
for searches allowing annotated SAPs/PTMs, and one for searches
allowing both annotated SAPs/PTMs as well as novel SAPs.
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Fig. 3. ROC curves for three different search strategies employed when
running RAId DbS.
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Summary of Organismal Databases Constructed
So far, we have finished constructing databses for 17 organisms. We
summarize these database in Table 2 below. Note that the disease
information is only available for the human database. For human
database, we have 123, 464 SAPs and 81, 984 PTMs. Out of those
SAPs and PTMs, 15, 787 of them have disease associations.
5
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Table 2. Summary of Augmented Organismal Databases Searchable by RAId DbS.
Organism DB name SAPs included PTMs included DB size (byte)
Homo sapiens hsa.seq 123464 81984 16,292,193
Anopheles gambiae angam.seq 350 50 6,042,277
Arabidopsis thaliana artha.seq 5207 11977 12,318,213
Bos taurus botau.seq 3295 15810 11,188,490
Caenorhabditis elegans caele.seq 1045 7756 10,050,609
Canis familiaris cafam.seq 2766 4196 18,458,474
Danio rerio darer.seq 7358 3841 14,477,794
Drosophila melanogaster drmel.seq 5611 9290 9,796,785
Equus caballus eqcab.seq 485 1045 9,404,150
Gallus gallus gagal.seq 1109 6522 8,728,501
Macaca mulatta mamul.seq 1370 1262 14,498,187
Mus musculus mumus.seq 27614 61684 14,363,491
Oryza sativa orsat.seq 1291 2182 10,679,924
Pan troglodytes patro.seq 5201 3734 20,227,873
Plasmodium falciparum plfal.seq 56 184 3,995,386
Rattus norvegicus ranor.seq 9297 33240 15,879,569
Saccharomyces cerevisiae sacer.seq 5507 13220 2,927,330
6
